267
Views
12
CrossRef citations to date
0
Altmetric
Review

Evaluating the use of PCR for diagnosing invasive aspergillosis

, , , &
Pages 603-610 | Received 15 Nov 2016, Accepted 28 Apr 2017, Published online: 10 May 2017

References

  • Karthaus M, Buchheidt D. Invasive aspergillosis: new insights into disease, diagnostic and treatment. Curr Pharm Des. 2013;19:3569–3594.
  • Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–e60. Epub 2016/07/02.
  • Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis. 2008;27:245–251. Epub 2008/01/15.
  • Barton RC. Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica. 2013;2013:459405. Epub 2013/11/28.
  • Marr KA, Laverdiere M, Gugel A, et al. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40:1762–1769. Epub 2005/05/24.
  • Buchheidt D, Hummel M. Aspergillus polymerase chain reaction (PCR) diagnosis. Med Mycol. 2005;43(Suppl 1):S139–S145. Epub 2005/08/23.
  • Halliday CL, Kidd SE, Sorrell TC, et al. Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer? Pathology. 2015;47:257–269. Epub 2015/02/27.
  • McCarthy MW, Walsh TJ. PCR methodology and applications for the detection of human fungal pathogens. Expert Rev Mol Diagn. 2016;16:1025–1036. Epub 2016/08/04.
  • Powers-Fletcher MV, Hanson KE. Molecular diagnostic testing for Aspergillus. J Clin Microbiol. 2016;54:2655–2660. Epub 2016/08/05.
  • White PL, Bretagne S, Klingspor L, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol. 2010;48:1231–1240. Epub 2010/02/12.
  • White PL, Perry MD, Loeffler J, et al. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol. 2010;48:3753–3755. Epub 2010/08/20.
  • Springer J, Morton CO, Perry M, et al. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. J Clin Microbiol. 2013;51:1445–1450. Epub 2013/02/22.
  • Herrera ML, Vallor AC, Gelfond JA, et al. Strain-dependent variation in 18S ribosomal DNA copy numbers in Aspergillus fumigatus. J Clin Microbiol. 2009;47:1325–1332. Epub 2009/03/06.
  • Skladny H, Buchheidt D, Baust C, et al. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol. 1999;37:3865–3871.
  • Landlinger C, Preuner S, Baskova L, et al. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia. 2010;24:2032–2038. Epub 2010/10/01.
  • Spiess B, Buchheidt D, Baust C, et al. Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol. 2003;41:1811–1818.
  • Alonso M, Escribano P, Guinea J, et al. Rapid detection and identification of Aspergillus from lower respiratory tract specimens by use of a combined probe-high-resolution melting analysis. J Clin Microbiol. 2012;50:3238–3243. Epub 2012/07/28.
  • Jones ME, Fox AJ, Barnes AJ, et al. PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients. J Clin Pathol. 1998;51:652–656. Epub 1999/02/04.
  • Hummel M, Spiess B, Kentouche K, et al. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol. 2006;44:3989–3993.
  • Cruciani M, Mengoli C, Loeffler J, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev. 2015;(10):CD009551. Epub 2015/09/08.
  • Alanio A, Bretagne S. Performance evaluation of multiplex PCR including Aspergillus-not so simple! Med Mycol. 2017 1;55(1):56–62.
  • Costa C, Costa JM, Desterke C, et al. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol. 2002;40:2224–2227. Epub 2002/05/31.
  • Loeffler J, Henke N, Hebart H, et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin Microbiol. 2000;38:586–590. Epub 2000/02/03.
  • Morrissey CO, Chen SC, Sorrell TC, et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis. 2013;13:519–528. Epub 2013/05/04.
  • Springer J, Lackner M, Nachbaur D, et al. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. Clin Microbiol Infect. 2016;22:80–86. Epub 2015/09/25.
  • Springer J, White PL, Hamilton S, et al. Comparison of performance characteristics of Aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations. J Clin Microbiol. 2016;54:705–711. Epub 2016/01/08.
  • Hebart H, Klingspor L, Klingebiel T, et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant. 2009;43:553–561. Epub 2008/12/17.
  • White PL, Perry MD, Barnes RA. An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett. 2009;296:1–10. Epub 2009/05/07.
  • Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther. 2009;7:1201–1221. Epub 2009/12/09.
  • Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol. 2007;24:89–94. Epub 2007/07/03.
  • Lass-Flörl C, Gunsilius E, Gastl G, et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol. 2004;42(9):4154-4157.
  • Boch T, Spiess B, Cornely OA, et al. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-beta-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. Clin Microbiol Infect. 2016;22(10):862-868.
  • Eigl S, Hoenigl M, Spiess B, et al. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. Med Mycol. 2016. Epub 2016/10/17.
  • Reinwald M, Hummel M, Kovalevskaya E, et al. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemoth. 2012;67:2260–2267.
  • Avni T, Levy I, Sprecher H, et al. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. J Clin Microbiol. 2012;50:3652–3658. Epub 2012/09/07.
  • Heng SC, Morrissey O, Chen SC, et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis. Crit Rev Microbiol. 2015;41:124–134. Epub 2013/06/27.
  • Fraczek MG, Kirwan MB, Moore CB, et al. Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR. Mycoses. 2014;57:69–78. Epub 2013/06/22.
  • Reinwald M, Spiess B, Heinz WJ, et al. Aspergillus PCR-based investigationof fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities. J Clin Microbiol. 2013;51(12):4178-4185.
  • Lass-Flörl C, Follett SA, Moody A, et al. Detection of Aspergillus in lung and other tissue samples using the MycAssay Aspergillus real-time PCR kit. Can J Microbiol. 2011;57:765–768. Epub 2011/08/25.
  • Rickerts V, Just-Nubling G, Konrad F, et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis. 2006;25:8–13. Epub 2006/01/18.
  • Lau A, Chen S, Sorrell T, et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol. 2007;45:380–385. Epub 2006/11/24.
  • Rickerts V, Khot PD, Myerson D, et al. Comparison of quantitative real time PCR with sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens. BMC Infect Dis. 2011;11:202. Epub 2011/07/28.
  • Reinwald M, Buchheidt D, Hummel M, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One. 2013;8:e56706.
  • Buchheidt D, Hummel M, Schleiermacher D, et al. Current molecular diagnostic approaches to systemic infections with aspergillus species in patients with hematological malignancies. Leuk Lymphoma. 2004;45:463–468.
  • Hummel M, Buchheidt D. Molecular and serological diagnosis of invasive aspergillosis: new answers to old questions? Mycoses. 2007;50(Suppl 1):18–23.
  • Aguado JM, Vazquez L, Fernandez-Ruiz M, et al. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. Clin Infect Dis. 2015;60:405–414. Epub 2014/10/23.
  • Heng SC, Chen SC, Morrissey CO, et al. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Diagn Microbiol Infect Dis. 2014;322–327.
  • Hoenigl MPJ, Spiess B, Wagner J, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52(6):2039–2045.
  • Johnson GL, Sarker SJ, Nannini F, et al. Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2015;53(7):2103–2108.
  • Chong GL, van de Sande WW, Dingemans GJ, et al. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. J Clin Microbiol. 2015;53:868–874. Epub 2015/01/09.
  • Chong GM, van der Beek MT, von dem Borne PA, et al. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay(R) in 201 patients with haematological disease suspected for invasive aspergillosis. J Antimicrob Chemother. 2016. Epub 2016/08/18.
  • Spiess B, Seifarth W, Merker N, et al. Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients. Antimicrob Agents Chemother. 2012;56:3905–3910.
  • Spiess B, Postina P, Reinwald M, et al. Incidence of cyp51 A key mutations in Aspergillus fumigatus - a study on primary clinical samples of immunocompromised patients in the period of 1995-2013. PLoS One. 2014;9(7):e103113.
  • Buchheidt D, Reinwald M, Spiess B, et al. Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients–is Aspergillus PCR appropriate? Mycoses. 2016;59:67–74. Epub 2016/01/13.
  • Babady NE, Miranda E, Gilhuley KA. Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. J Clin Microbiol. 2011;49:3777–3782. Epub 2011/09/02.
  • Mancini N, Clerici D, Diotti R, et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol. 2008;57:601–604. Epub 2008/04/26.
  • von Lilienfeld-Toal M, Lehmann LE, Raadts AD, et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol. 2009;47:2405–2410. Epub 2009/07/03.
  • Lamoth F, Jaton K, Prod’hom G, et al. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol. 2010;48:3510–3516. Epub 2010/08/20.
  • Steinmann J, Buer J, Rath PM. Detection of Aspergillus fumigatus in blood samples from critically ill patients in intensive care units by use of the SeptiFast assay. J Clin Microbiol. 2016;54:1918–1921. Epub 2016/05/06.
  • White PL, Posso RB, Barnes RA. Analytical and clinical evaluation of the PathoNostics AsperGenius assay for detection of invasive aspergillosis and resistance to azole antifungal drugs during testing of serum samples. J Clin Microbiol. 2015;53:2115–2121. Epub 2015/04/24.
  • White PL, Wingard JR, Bretagne S, et al. Aspergillus PCR: a systematic review of evidence for clinical use in comparison with antigen testing. Clin Infect Dis. 2015;61:1293–1303. Epub 2015/06/27.
  • Lyon GM, Abdul-Ali D, Loeffler J, et al. Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis. J Clin Microbiol. 2013;51:2403–2405. Epub 2013/04/26.
  • White PL, Hibbitts SJ, Perry MD, et al. Evaluation of a commercially developed semiautomated PCR-surface-enhanced raman scattering assay for diagnosis of invasive fungal disease. J Clin Microbiol. 2014;52:3536–3543. Epub 2014/07/18.
  • Bacconi A, Richmond GS, Baroldi MA, et al. Improved sensitivity for molecular detection of bacterial and Candida infections in blood. J Clin Microbiol. 2014;52:3164–3174. Epub 2014/06/22.
  • Shin JH, Ranken R, Sefers SE, et al. Detection, identification, and distribution of fungi in bronchoalveolar lavage specimens by use of multilocus PCR coupled with electrospray ionization/mass spectrometry. J Clin Microbiol. 2013;51:136–141. Epub 2012/10/27.
  • Huggett JF, Cowen S, Foy CA. Considerations for digital PCR as an accurate molecular diagnostic tool. Clin Chem. 2015;61:79–88. Epub 2014/10/24.
  • Huggett JF, Whale A. Digital PCR as a novel technology and its potential implications for molecular diagnostics. Clin Chem. 2013;59:1691–1693. Epub 2013/10/09.
  • Alanio A, Sturny-Leclere A, Benabou M, et al. Variation in copy number of the 28S rDNA of Aspergillus fumigatus measured by droplet digital PCR and analog quantitative real-time PCR. J Microbiol Methods. 2016;127:160–163. Epub 2016/06/19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.